Literature DB >> 20423346

A novel role for the metabotropic glutamate receptor-7: modulation of faecal water content and colonic electrolyte transport in the mouse.

M Julio-Pieper1, N P Hyland, J A Bravo, T G Dinan, J F Cryan.   

Abstract

BACKGROUND AND
PURPOSE: Increasing evidence implicates metabotropic glutamate receptor mGlu(7) in the pathophysiology of stress-related disorders such as depression and anxiety. Mood disorders are frequently associated with gastrointestinal (GI) dysfunction; however, the role of mGlu(7) receptors outside the CNS is unknown. This present study investigated the expression and possible functional role of mGlu(7) receptors in the mouse colon. EXPERIMENTAL APPROACH: Expression of mGlu(7) receptor mRNA and protein was studied in mouse colon by in situ hybridization and Western blotting. Effects of the selective mGlu(7) receptor agonist AMN082 on defecation and faecal parameters were studied in an isolation-induced stress model. AMN082 effects on ion transport and neuronal intracellular signalling were examined via Ussing chambers and calcium imaging. KEY
RESULTS: mGlu(7) receptor mRNA and protein were highly expressed in colon mucosa. Stress-induced faecal output was unaffected by AMN082, although faecal water content was increased. In mucosa/submucosa preparations, 100 nM and 1 microM AMN082 increased bethanechol-induced changes in short-circuit current in the Ussing chamber. This was sensitive to tetrodotoxin. Also, 100 nM AMN082 significantly increased calcium signalling in a subset of submucosal neurons. CONCLUSIONS AND IMPLICATIONS: Activating mGlu(7) receptors increased colonic secretory function in vivo and ex vivo. In a group of submucosal neurons, AMN082 strongly induced calcium signalling and the presence of submucosal nerves was required for the AMN082-dependent increase in secretion. These data suggest that targeting mGlu(7) receptors may be useful in the treatment of central components of stress disorders and also stress-associated GI dysfunction such as diarrhoea or constipation.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20423346      PMCID: PMC2874858          DOI: 10.1111/j.1476-5381.2010.00713.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  41 in total

1.  mGluR7 facilitates extinction of aversive memories and controls amygdala plasticity.

Authors:  M Fendt; S Schmid; D R Thakker; L H Jacobson; R Yamamoto; K Mitsukawa; R Maier; F Natt; D Hüsken; P H Kelly; K H McAllister; D Hoyer; H van der Putten; J F Cryan; P J Flor
Journal:  Mol Psychiatry       Date:  2007-08-21       Impact factor: 15.992

2.  Selective activation of metabotropic G-protein-coupled glutamate 7 receptor elicits anxiolytic-like effects in mice by modulating GABAergic neurotransmission.

Authors:  Katarzyna Stachowicz; Piotr Brañski; Kinga Kłak; Herman van der Putten; John F Cryan; Peter J Flor; Pilc Andrzej
Journal:  Behav Pharmacol       Date:  2008-09       Impact factor: 2.293

3.  5-Hydroxytryptophan activates colonic myenteric neurons and propulsive motor function through 5-HT4 receptors in conscious mice.

Authors:  L Wang; V Martínez; H Kimura; Y Taché
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2006-09-21       Impact factor: 4.052

4.  Frequency and severity of the symptoms of irritable bowel syndrome across the anxiety disorders and depression.

Authors:  Daniel F Gros; Martin M Antony; Randi E McCabe; Richard P Swinson
Journal:  J Anxiety Disord       Date:  2008-08-27

5.  GRM7 variants confer susceptibility to age-related hearing impairment.

Authors:  Rick A Friedman; Lut Van Laer; Matthew J Huentelman; Sonal S Sheth; Els Van Eyken; Jason J Corneveaux; Waibhav D Tembe; Rebecca F Halperin; Ashley Q Thorburn; Sofie Thys; Sarah Bonneux; Erik Fransen; Jeroen Huyghe; Ilmari Pyykkö; Cor W R J Cremers; Hannie Kremer; Ingeborg Dhooge; Dafydd Stephens; Eva Orzan; Markus Pfister; Michael Bille; Agnete Parving; Martti Sorri; Paul H Van de Heyning; Linna Makmura; Jeffrey D Ohmen; Frederick H Linthicum; Jose N Fayad; John V Pearson; David W Craig; Dietrich A Stephan; Guy Van Camp
Journal:  Hum Mol Genet       Date:  2008-12-01       Impact factor: 6.150

Review 6.  Metabolism and functions of L-glutamate in the epithelial cells of the small and large intestines.

Authors:  François Blachier; Claire Boutry; Cécile Bos; Daniel Tomé
Journal:  Am J Clin Nutr       Date:  2009-07-01       Impact factor: 7.045

7.  Desipramine prevents stress-induced changes in depressive-like behavior and hippocampal markers of neuroprotection.

Authors:  Javier A Bravo; Gabriela Díaz-Veliz; Sergio Mora; José L Ulloa; Viviana M Berthoud; Paola Morales; Sandor Arancibia; Jenny Lucy Fiedler
Journal:  Behav Pharmacol       Date:  2009-05       Impact factor: 2.293

8.  Nasal solitary chemoreceptor cell responses to bitter and trigeminal stimulants in vitro.

Authors:  Brian D Gulbransen; Tod R Clapp; Thomas E Finger; Sue C Kinnamon
Journal:  J Neurophysiol       Date:  2008-04-16       Impact factor: 2.714

9.  Contribution of the pst-phoU operon to cell adherence by atypical enteropathogenic Escherichia coli and virulence of Citrobacter rodentium.

Authors:  Catherine Cheng; Sharon M Tennant; Kristy I Azzopardi; Vicki Bennett-Wood; Elizabeth L Hartland; Roy M Robins-Browne; Marija Tauschek
Journal:  Infect Immun       Date:  2009-03-02       Impact factor: 3.441

10.  In vitro pharmacological characterization of novel isoxazolopyridone derivatives as allosteric metabotropic glutamate receptor 7 antagonists.

Authors:  Gentaroh Suzuki; Naohiro Tsukamoto; Hiroshi Fushiki; Aki Kawagishi; Masayuki Nakamura; Hideki Kurihara; Morihiro Mitsuya; Mitsuru Ohkubo; Hisashi Ohta
Journal:  J Pharmacol Exp Ther       Date:  2007-07-03       Impact factor: 4.030

View more
  8 in total

Review 1.  Group III metabotropic glutamate receptors: pharmacology, physiology and therapeutic potential.

Authors:  Marion S Mercier; David Lodge
Journal:  Neurochem Res       Date:  2014-08-22       Impact factor: 3.996

2.  Interleukin-6 modulates colonic transepithelial ion transport in the stress-sensitive wistar kyoto rat.

Authors:  Dervla O'Malley; Timothy G Dinan; John F Cryan
Journal:  Front Pharmacol       Date:  2012-11-07       Impact factor: 5.810

3.  Resistance to early-life stress in mice: effects of genetic background and stress duration.

Authors:  Hélène M Savignac; Timothy G Dinan; John F Cryan
Journal:  Front Behav Neurosci       Date:  2011-04-04       Impact factor: 3.558

Review 4.  Metabotropic Glutamate Receptor 7: From Synaptic Function to Therapeutic Implications.

Authors:  Enza Palazzo; Ida Marabese; Vito de Novellis; Francesco Rossi; Sabatino Maione
Journal:  Curr Neuropharmacol       Date:  2016       Impact factor: 7.363

5.  Activating metabotropic glutamate receptor‑7 attenuates visceral hypersensitivity in neonatal maternally separated rats.

Authors:  Limei Shao; Yanbing Liu; Junhua Xiao; Qunying Wang; Fei Liu; Jin Ding
Journal:  Int J Mol Med       Date:  2018-12-11       Impact factor: 4.101

6.  Systemic injection of nicotinic acetylcholine receptor antagonist mecamylamine affects licking, eyelid size, and locomotor and autonomic activities but not temporal prediction in male mice.

Authors:  Shohei Kaneko; Koji Toda; Yasuyuki Niki; Kota Yamada; Daiki Nasukawa; Yusuke Ujihara
Journal:  Mol Brain       Date:  2022-09-06       Impact factor: 4.399

Review 7.  The Emerging Role of Metabotropic Glutamate Receptors in the Pathophysiology of Chronic Stress-Related Disorders.

Authors:  Daniel Peterlik; Peter J Flor; Nicole Uschold-Schmidt
Journal:  Curr Neuropharmacol       Date:  2016       Impact factor: 7.363

Review 8.  The Neuro-endocrinological Role of Microbial Glutamate and GABA Signaling.

Authors:  Roberto Mazzoli; Enrica Pessione
Journal:  Front Microbiol       Date:  2016-11-30       Impact factor: 5.640

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.